Evidence map›Paper›PMID 41637692›Full record

ArticleCPT: pharmacometrics & systems pharmacology2026

Stochastic Gates for Covariate Selection in Population Pharmacokinetics Modeling.

Marija Kekic, Oleg Stepanov, Wenjuan Wang, Sam Richardson, Damilola Olabode, Carlos Traynor, Richard Dearden, Diansong Zhou, Weifeng Tang, Megan Gibbs and 1 more

Abstract read
In one paragraph

Article in CPT: pharmacometrics & systems pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Marija KekicPredictive AI & Data, Clinical Pharmacology & Safety Sciences, R&D BioPharmaceuticals, AstraZeneca, Barcelona, Spain.ORCID https://orcid.org/0000-0002-2731-5788
Oleg StepanovClinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D BioPharmaceuticals, AstraZeneca, Cambridge, UK.ORCID https://orcid.org/0000-0001-6129-6499
Wenjuan WangPredictive AI & Data, Clinical Pharmacology & Safety Sciences, R&D BioPharmaceuticals, AstraZeneca, Cambridge, UK.ORCID https://orcid.org/0000-0002-1879-7332
Sam RichardsonPredictive AI & Data, Clinical Pharmacology & Safety Sciences, R&D BioPharmaceuticals, AstraZeneca, Cambridge, UK.ORCID https://orcid.org/0000-0001-6781-3768
Damilola OlabodeClinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D BioPharmaceuticals, AstraZeneca, Waltham, MA, USA.ORCID https://orcid.org/0000-0001-7675-5707
Carlos TraynorClinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D BioPharmaceuticals, AstraZeneca, Barcelona, Spain.ORCID https://orcid.org/0000-0002-3753-7552
Richard DeardenPredictive AI & Data, Clinical Pharmacology & Safety Sciences, R&D BioPharmaceuticals, AstraZeneca, Cambridge, UK.ORCID https://orcid.org/0009-0000-0807-6606
Diansong ZhouClinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D BioPharmaceuticals, AstraZeneca, Waltham, MA, USA.ORCID https://orcid.org/0000-0002-2673-1069
Weifeng TangClinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D BioPharmaceuticals, AstraZeneca, Gaithersburg, MD, USA.ORCID https://orcid.org/0000-0002-8261-8116
Megan GibbsClinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D BioPharmaceuticals, AstraZeneca, Gaithersburg, MD, USA.
Andrzej NowojewskiPredictive AI & Data, Clinical Pharmacology & Safety Sciences, R&D BioPharmaceuticals, AstraZeneca, Cambridge, UK.ORCID https://orcid.org/0009-0005-7729-8452

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Covariate selection in population pharmacokinetics modeling is essential for understanding interindividual variability in drug response and optimizing dosing. Traditional stepwise covariate modeling is often time-consuming, compared to the new machine learning alternatives. This study investigates the use of neural networks with stochastic gates for automated covariate selection, aiming to efficiently identify relevant covariates while penalizing excessive covariate inclusion. On various synthetic datasets, the approach demonstrated robustness in detecting important covariates, overcoming challenges such as high correlations, low covariate frequencies, high interindividual variability, and complex covariate dependencies. In real clinical data from a monalizumab study, the method successfully identified covariates that matched those found by experts. However, for tixagevimab/cilgavimab, it identified a superset of covariates, indicating a potential need for further pruning. This machine learning-based method enhances the covariate preselection process in population pharmacokinetics model development, offering significant time savings and improving efficiency even under challenging scenarios.

Indexed as

Models, BiologicalNeural Networks, ComputerPharmacokineticsHumansMachine LearningStochastic Processes

Identifiers

PMID41637692
PMCPMC12872115

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.